In 2022, Frank McCormick earned $1.15M in total compensation at Olema Pharmaceuticals, Inc., including $647.00K salary and $489.00K bonus. Most recently sold 100,000 shares in Dec 2023. Currently holds stock worth $13.63M. Led Olema Pharmaceuticals, Inc. as CEO for 1 years.
Compensation History
Annual executive compensation data for Frank McCormick, including salary, bonuses, and stock awards.
Year
2022
Total Compensation
$1.15M
Salary
$647.00K
Bonus
$489.00K
Other
$14.37K
Salary
$647.00KBoard Justification
The compensation policies and decisions are designed to attract and retain talented executives by paying for performance and aligning compensation with stockholder interests.
Bonus
$489.00KBoard Justification
Annual performance-based cash bonuses based on the achievement of certain corporate performance objectives and individual performance during 2023.
Other Compensation
$14.37KBoard Justification
Consists of $13,200 employer matching 401(k) contributions and $1,170 life insurance premium paid as an employee benefit.
Restricted Stock
Board Justification
No specific vested stock amount provided for 2023 in the summary compensation table.
Performance Metrics
Performance-based bonuses based on corporate goals including clinical development milestones and financial objectives.
Frank McCormick
Ex-CEO of Olema Pharmaceuticals, Inc.
Education
D.Sc. (Hon) from University of Cambridge
Field of Expertise
Other - Science
Sector of Economy
Healthcare
Born
May 1, 1958 - 67 years ago
CEO of Olema Pharmaceuticals, Inc. for
1 year 6 months (Apr 2022 - Oct 2023)
Previous Experience
Director at Olema Pharmaceuticals, Inc.
Holdings
Track Frank McCormick's stock holdings and portfolio value over time.
Total Stock Sold
$12.21M
$12.21M
300,000 BBIO shares
What if they kept their stock?
If Frank McCormick didn't sell their stock, today they would have:
Extra BBIO300,000 shares worth $22.09M.
This is 80.92% and $9.88M more than what they got when they sold the stock.
Insider Trading
Frank McCormick's recent stock transactions, purchases, and sales filed with the SEC.
$4.21M
BBIO at $42.06/share
Dec 26, 2023
Sale
$4.29M
BBIO at $42.90/share
Nov 13, 2020
Sale
39,042 shares
BBIO
May 19, 2020
Received
$3.90M
BBIO at $38.98/share
Dec 27, 2019
Sale
Rivals
Compare Frank McCormick with competitor CEOs and industry peers.